Evidence map›Paper›PMID 23649808›Full record

ArticleThe Journal of cell biology2013

p53-dependent release of Alarmin HMGB1 is a central mediator of senescent phenotypes.

Albert R Davalos, Misako Kawahara, Gautam K Malhotra, Nicholas Schaum, Jiahao Huang, Urvi Ved, Christian M Beausejour, Jean-Philippe Coppe, Francis Rodier, Judith Campisi

Open access · greenAbstract read
In one paragraph

Article in The Journal of cell biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 282 papers.

0numbers the graph read from it
0cells of the map it votes in
282citing papers in PubMed
9.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

282 citing papers in PubMed, 431 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. HMGB1: A Central Node in Cancer Therapy Resistance.International journal of molecular sciences · 2025
    Review

222 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Albert R DavalosLawrence Berkeley National Laboratory, Life Sciences Division, Berkeley, CA 94720, USA.
Misako Kawahara
Gautam K Malhotra
Nicholas Schaum
Jiahao Huang
Urvi Ved
Christian M Beausejour
Jean-Philippe Coppe
Francis Rodier
Judith Campisi
Lawrence Berkeley National Laboratory · USBuck Institute for Research on Aging · USCentre Hospitalier Universitaire Sainte-Justine · CA

Funding

THE IMPACT OF CELLULAR DEFENSE ON THE ROLE OF Ku80 IN GENOME MAINTENANCE AND LONGP01AG017242 · NIA · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI VIJG, JAN · 1999 to 2023
$46.1M
CELLULAR SENESCENCE AND CONTROL OF GENE EXPRESSIONR37AG009909 · NIA · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI CAMPISI, JUDITH · 1995 to 2015
$7.6M
Cellular senescence and control of gene expressionR56AG009909 · NIA · BUCK INSTITUTE FOR RESEARCH ON AGING · PI CAMPISI, JUDITH · 2017 to 2017
$592k
CELLULAR SENESCENCE AND CONTROL OF GENE EXPRESSIONR01AG009909 · NIA · UNIVERSITY OF CALIFORNIA BERKELEY · PI CAMPISI, JUDITH · 1990 to 1994
–
NIA NIH HHS AG017242NIA NIH HHS AG09909NIA NIH HHS P01 AG017242NIA NIH HHS R37 AG009909NIA NIH HHS R56 AG009909
6 · The paper itself

Abstract

Cellular senescence irreversibly arrests proliferation in response to potentially oncogenic stress. Senescent cells also secrete inflammatory cytokines such as IL-6, which promote age-associated inflammation and pathology. HMGB1 (high mobility group box 1) modulates gene expression in the nucleus, but certain immune cells secrete HMGB1 as an extracellular Alarmin to signal tissue damage. We show that nuclear HMGB1 relocalized to the extracellular milieu in senescent human and mouse cells in culture and in vivo. In contrast to cytokine secretion, HMGB1 redistribution required the p53 tumor suppressor, but not its activator ATM. Moreover, altered HMGB1 expression induced a p53-dependent senescent growth arrest. Senescent fibroblasts secreted oxidized HMGB1, which stimulated cytokine secretion through TLR-4 signaling. HMGB1 depletion, HMGB1 blocking antibody, or TLR-4 inhibition attenuated senescence-associated IL-6 secretion, and exogenous HMGB1 stimulated NF-κB activity and restored IL-6 secretion to HMGB1-depleted cells. Our findings identify senescence as a novel biological setting in which HMGB1 functions and link HMGB1 redistribution to p53 activity and senescence-associated inflammation.

Indexed as

Gene Expression RegulationAnimalsAtaxia Telangiectasia Mutated ProteinsCell Cycle ProteinsCell NucleusCell ProliferationCellular SenescenceCyclin-Dependent Kinase Inhibitor p16CytokinesDNA-Binding ProteinsFibroblastsHMGB1 ProteinHumansInflammationInterleukin-6MiceAtaxia Telangiectasia Mutated ProteinsATM protein, humanAtm protein, mouseCell Cycle ProteinsCyclin-Dependent Kinase Inhibitor p16CytokinesDNA-Binding ProteinsHMGB1 ProteinInterleukin-6NF-kappa BProtein Serine-Threonine KinasesTLR4 protein, humanTlr4 protein, mouseToll-Like Receptor 4TP53 protein, humanTumor Suppressor Protein p53Tumor Suppressor Proteins

Identifiers

PMID23649808
PMCPMC3653366
OpenAlexW2162229546

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.